The role of aberrant TGF-β /Smad4 signaling in epigenetic silencing of RunX1T1 in ovarian cancer and cancer initiating cells
碩士 === 國立中正大學 === 生命科學系暨分子生物研究所暨生物醫學研究 === 97 === Ovarian cancer is one of the ten leading causes of cancer death among women. Multiple genetic and epigenetic alterations play important roles in ovarian carcinogenesis. Moreover, aberrant TGF-β signaling pathway is recently demonstrated to be crucial...
Main Authors: | Hui-Wen Yang, 楊惠雯 |
---|---|
Other Authors: | Michael Wing-Yan Chan |
Format: | Others |
Language: | en_US |
Published: |
2009
|
Online Access: | http://ndltd.ncl.edu.tw/handle/75102674954648715238 |
Similar Items
-
The Role of Aberrant Epigenetic Alteration of the TGF-β Targets FBXO32 and ABCA1 In Ovarian Cancer
by: Jian-Liang Chou, et al.
Published: (2013) -
TGFΒ/SMAD4 Signaling and Altered Epigenetics Contribute to Increased Ovarian Cancer Severity
by: Deatherage, Daniel E.
Published: (2011) -
Aberrant Transforming Growth Factor β1 Signaling and SMAD4 Nuclear Translocation Confer Epigenetic Repression of ADAM19 in Ovarian Cancer
by: Michael W.Y. Chan, et al.
Published: (2008-09-01) -
The Role of EZH2 in the Epigenetic Silencing of the TGF-β Target and Putative Tumor Suppressor, LTBP2, in Ovarian Cancer
by: Jacqueline Shay, et al.
Published: (2014) -
Downregulation of TGF-β1 suppressed proliferation and increased chemosensitivity of ovarian cancer cells by promoting BRCA1/Smad3 signaling
by: Yanqiu Wang, et al.
Published: (2018-12-01)